MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 126 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $812,000 | -7.9% | 12,169 | +25.7% | 0.25% | -10.4% |
Q4 2019 | $882,000 | +3.4% | 9,678 | -2.2% | 0.28% | +9.8% |
Q3 2019 | $853,000 | -76.6% | 9,896 | -71.5% | 0.25% | -69.2% |
Q2 2019 | $3,641,000 | +50.8% | 34,736 | +80.2% | 0.83% | +53.2% |
Q1 2019 | $2,414,000 | +12.1% | 19,273 | +0.9% | 0.54% | +3.5% |
Q4 2018 | $2,153,000 | -14.3% | 19,099 | +62.8% | 0.52% | +11.6% |
Q3 2018 | $2,512,000 | – | 11,732 | – | 0.47% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthCor Management, L.P. | 1,402,250 | $93,614,000 | 4.00% |
Parkman Healthcare Partners LLC | 30,000 | $2,003,000 | 0.93% |
ARMISTICE CAPITAL, LLC | 216,000 | $14,420,000 | 0.89% |
Avoro Capital Advisors LLC | 349,000 | $23,299,000 | 0.79% |
Rock Springs Capital Management LP | 250,000 | $16,690,000 | 0.69% |
Capital Impact Advisors, LLC | 24,351 | $1,626,000 | 0.68% |
Baker Brothers Advisors | 1,499,212 | $100,087,000 | 0.62% |
EWG Elevate Inc. | 11,086 | $740,000 | 0.56% |
SHIKIAR ASSET MANAGEMENT INC | 12,000 | $801,000 | 0.54% |
DAFNA Capital Management LLC | 13,600 | $908,000 | 0.38% |